NCT02266589View on ClinicalTrials.gov

Stress Doses of Hydrocortisone on Coagulation Dysfunction in Patients With Septic Shock

PHASE3CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Septic ShockSepsis
Interventions
DRUG

Hydrocortisone

Hydrocortisone hemisuccinate (Roussel-Uclaf, Romainville, France), 50 mg intravenously every 6 hrs

All Listed Sponsors
lead

Nanjing PLA General Hospital

OTHER

NCT02266589 - Stress Doses of Hydrocortisone on Coagulation Dysfunction in Patients With Septic Shock | Biotech Hunter | Biotech Hunter